
Company valuation, historical trends, and peer comparisons.
According to GH Research PLC’s latest financial reports and current stock price. The company's current Enterprise Value is 1.02B. This represents a change of 25.81% compared to the average of 813.43M of the last 4 quarters.
The mean historical Enterprise Value of GH Research PLC over the last ten years is 487.37M. The current 1.02B Enterprise Value has changed 109.97% with respect to the historical average. Over the past ten years (40 quarters), GHRS's Enterprise Value was at its highest in in the June 2026 quarter at 1.44B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
487.37M
Median
529.50M
Minimum
224.29M
Maximum
936.87M
Discovering the peaks and valleys of GH Research PLC Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 100.55%
Maximum Annual Enterprise Value = 936.87M
Minimum Annual Increase = -63.74%
Minimum Annual Enterprise Value = 224.29M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 529.50M | 100.55% |
| 2024 | 264.03M | 17.72% |
| 2023 | 224.29M | -33.97% |
| 2022 | 339.69M | -63.74% |
| 2021 | 936.87M | 61.89% |
| 2020 | 578.71M | 7.47% |
The current Enterprise Value of GH Research PLC (GHRS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
339.27M
5-year avg
458.88M
10-year avg
487.37M
GH Research PLC’s Enterprise Value is greater than Alto Neuroscience, Inc. (677.66M), less than LB Pharmaceuticals Inc Common Stock (1.04B), greater than MapLight Therapeutics, Inc. (216.32M), less than Rapport Therapeutics, Inc. Common Stock (1.18B), less than Mind Medicine (MindMed) Inc. (3.77B), greater than Neumora Therapeutics, Inc. Common Stock (-10144921.00), greater than Minerva Neurosciences, Inc. (98.06M), less than Biohaven Ltd. (2.51B), greater than VistaGen Therapeutics, Inc. (-8029337.00), less than Seaport Therapeutics, Inc. Common Stock (1.07B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 677.66M | $914.34M | |
| 1.04B | $1.32B | |
| 216.32M | $285.97M | |
| 1.18B | $1.24B | |
| 3.77B | $4.39B | |
| -10144921.00 | $106.35M | |
| 98.06M | $122.71M | |
| 2.51B | $2.30B | |
| -8029337.00 | $8.18M | |
| 1.07B | $1.12B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GH Research PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GH Research PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is GH Research PLC's Enterprise Value?
What is the highest Enterprise Value for GH Research PLC (GHRS)?
What is the 3-year average Enterprise Value for GH Research PLC (GHRS)?
What is the 5-year average Enterprise Value for GH Research PLC (GHRS)?
How does the current Enterprise Value for GH Research PLC (GHRS) compare to its historical average?